Novanta Inc. (NOVT) 10-Year Financial Performance & Capital Metrics

NOVT • • Industrial / General

TechnologyTech Hardware & EquipmentOptical & Photonics SystemsLaser & Optical Components

AboutNovanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.Show more

Revenue $949M +7.7%
EBITDA $166M +5.8%
Net Income $64M -12.1%
EPS (Diluted) 1.77 -12.4%
Gross Margin 44.41% -2.1%
EBITDA Margin 17.5% -1.8%
Operating Margin 11.65% -7.0%
Net Margin 6.75% -18.3%
ROE 9.03% -22.5%
ROIC 7.99% -6.5%
Debt/Equity 0.63 +5.1%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗Weak Piotroski F-Score: 3/9

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y10.04%

5Y8.68%

3Y10.33%

TTM4.07%

Profit (Net Income) CAGR

10Y-

5Y9.47%

3Y8.39%

TTM-12.16%

EPS CAGR

10Y-

5Y9.01%

3Y7.87%

TTM-11.98%

ROCE

10Y Avg9.3%

5Y Avg8.84%

3Y Avg9.84%

Latest9.58%

Peer Comparison

Laser & Optical Components

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NOVTNovanta Inc.	4.76B	133.18	75.24	7.67%	5.5%	6.59%	2.97%	0.63
SELXSemilux International Ltd. Ordinary Shares	34.43M	0.92	-0.15	-67.94%	-165.22%	-31.41%		0.52
COHRCoherent, Inc.	30.8B	195.96	-376.85	23.42%	4.13%	2.88%	0.63%	0.46

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	373.6M	384.76M	521.29M	614.34M	626.1M	590.62M	706.79M	860.9M	881.66M	949.25M
Revenue Growth %	0.02%	0.03%	0.35%	0.18%	0.02%	-0.06%	0.2%	0.22%	0.02%	0.08%
Cost of Goods Sold+	215.71M	222.31M	300.76M	352.81M	364.01M	346.11M	406.46M	482.43M	481.76M	527.7M
COGS % of Revenue	0.58%	0.58%	0.58%	0.57%	0.58%	0.59%	0.58%	0.56%	0.55%	0.56%
Gross Profit+	157.89M	162.45M	220.53M	261.53M	262.08M	244.52M	300.33M	378.47M	399.9M	421.55M
Gross Margin %	0.42%	0.42%	0.42%	0.43%	0.42%	0.41%	0.42%	0.44%	0.45%	0.44%
Gross Profit Growth %	0.05%	0.03%	0.36%	0.19%	0%	-0.07%	0.23%	0.26%	0.06%	0.05%
Operating Expenses+	128.96M	129.5M	162.97M	190.51M	206.8M	188.63M	236.27M	275.39M	289.4M	310.96M
OpEx % of Revenue	0.35%	0.34%	0.31%	0.31%	0.33%	0.32%	0.33%	0.32%	0.33%	0.33%
Selling, General & Admin	82.05M	81.69M	102.03M	115.9M	118.41M	109.85M	129.16M	158.9M	164.46M	175.94M
SG&A % of Revenue	0.22%	0.21%	0.2%	0.19%	0.19%	0.19%	0.18%	0.18%	0.19%	0.19%
Research & Development	31.04M	32M	41.67M	51.02M	55.97M	61M	72.52M	85.77M	91.68M	95.52M
R&D % of Revenue	0.08%	0.08%	0.08%	0.08%	0.09%	0.1%	0.1%	0.1%	0.1%	0.1%
Other Operating Expenses	15.87M	15.8M	19.27M	23.59M	32.43M	17.78M	34.6M	30.72M	33.26M	39.5M
Operating Income+	28.93M	32.95M	57.57M	71.01M	55.28M	55.89M	64.05M	103.08M	110.5M	110.58M
Operating Margin %	0.08%	0.09%	0.11%	0.12%	0.09%	0.09%	0.09%	0.12%	0.13%	0.12%
Operating Income Growth %	2.72%	0.14%	0.75%	0.23%	-0.22%	0.01%	0.15%	0.61%	0.07%	0%
EBITDA+	48.05M	53.31M	88.32M	108.06M	93.56M	94.18M	107.45M	156.24M	157.11M	166.15M
EBITDA Margin %	0.13%	0.14%	0.17%	0.18%	0.15%	0.16%	0.15%	0.18%	0.18%	0.18%
EBITDA Growth %	5.87%	0.11%	0.66%	0.22%	-0.13%	0.01%	0.14%	0.45%	0.01%	0.06%
D&A (Non-Cash Add-back)	19.11M	20.36M	30.76M	37.05M	38.28M	38.29M	43.39M	53.16M	46.61M	55.56M
EBIT	37.19M	40.9M	65.11M	79.05M	71.86M	59.7M	82.07M	107.46M	123.31M	124.29M
Net Interest Income+	-5.18M	-4.56M	-7.17M	-9.81M	-8.49M	-6.56M	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	5.18M	4.56M	7.17M	9.81M	8.49M	6.56M	0	0	0	0
Other Income/Expense	17.09M	-433K	18.57M	-9.71M	-9.52M	-7.49M	-7.88M	-15.92M	-26.75M	-31.52M
Pretax Income+	46.02M	32.52M	76.13M	61.3M	45.77M	48.4M	56.17M	87.16M	83.75M	79.07M
Pretax Margin %	0.12%	0.08%	0.15%	0.1%	0.07%	0.08%	0.08%	0.1%	0.09%	0.08%
Income Tax+	10.39M	10.52M	13.83M	10.21M	4.99M	3.88M	5.84M	13.11M	10.87M	14.98M
Effective Tax Rate %	0.77%	0.68%	0.79%	0.8%	0.89%	0.92%	0.9%	0.85%	0.87%	0.81%
Net Income+	35.62M	22M	60.05M	49.11M	40.77M	44.52M	50.33M	74.05M	72.88M	64.09M
Net Margin %	0.1%	0.06%	0.12%	0.08%	0.07%	0.08%	0.07%	0.09%	0.08%	0.07%
Net Income Growth %	2.47%	-0.38%	1.73%	-0.18%	-0.17%	0.09%	0.13%	0.47%	-0.02%	-0.12%
Net Income (Continuing)	35.63M	22M	62.31M	51.09M	40.77M	44.52M	50.33M	74.05M	72.88M	64.09M
Discontinued Operations	-13K	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	46.92M	0	0	0	0	0	0	0
EPS (Diluted)+	1.02	0.63	1.13	1.43	1.15	1.25	1.41	2.06	2.02	1.77
EPS Growth %	2.46%	-0.38%	0.79%	0.27%	-0.2%	0.09%	0.13%	0.46%	-0.02%	-0.12%
EPS (Basic)	1.03	0.63	1.14	1.46	1.16	1.27	1.42	2.08	2.03	1.78
Diluted Shares Outstanding	34.83M	34.91M	35.28M	35.47M	35.55M	35.65M	35.78M	35.91M	36.03M	36.12M
Basic Shares Outstanding	34.58M	34.69M	34.82M	34.91M	35.03M	35.14M	35.4M	35.65M	35.84M	35.95M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	185.21M	199.25M	287.88M	281.77M	304.51M	304.17M	373.82M	420.52M	415.3M	433.65M
Cash & Short-Term Investments	59.96M	68.11M	100.06M	82.04M	78.94M	125.05M	117.39M	100.11M	105.05M	113.99M
Cash Only	59.96M	68.11M	100.06M	82.04M	78.94M	125.05M	117.39M	100.11M	105.05M	113.99M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	59.7M	63.77M	81.48M	83.95M	91.08M	75.05M	115.62M	137.7M	139.41M	151.03M
Days Sales Outstanding	58.32	60.49	57.05	49.88	53.1	46.38	59.71	58.38	57.71	58.07
Inventory	59.57M	59.74M	91.28M	104.76M	116.62M	92.74M	125.66M	168M	149.37M	144.61M
Days Inventory Outstanding	100.79	98.09	110.77	108.38	116.93	97.8	112.84	127.1	113.17	100.02
Other Current Assets	5.99M	7.63M	15.06M	11.01M	17.87M	11.33M	15.16M	14.72M	21.46M	24.03M
Total Non-Current Assets+	230.83M	226.39M	438.82M	437.81M	565.22M	561.01M	854.06M	820.69M	810.76M	954.86M
Property, Plant & Equipment	40.55M	35.42M	61.72M	65.46M	112.74M	113.12M	135.78M	146.5M	147.75M	156.04M
Fixed Asset Turnover	9.21x	10.86x	8.45x	9.38x	5.55x	5.22x	5.21x	5.88x	5.97x	6.08x
Goodwill	103.46M	108.13M	210.99M	217.66M	274.71M	285.98M	479.5M	478.9M	484.51M	584.1M
Intangible Assets	66.27M	61.74M	155.05M	142.92M	166.18M	148.52M	220.99M	175.77M	145.02M	185.84M
Long-Term Investments	10.1M	8.5M	0	0	0	0	0	0	0	0
Other Non-Current Assets	12.67M	12.5M	4.02M	2.27M	2.71M	2.89M	5.59M	4.41M	5.62M	5.99M
Total Assets+	416.05M	425.64M	726.7M	719.58M	869.74M	865.18M	1.23B	1.24B	1.23B	1.39B
Asset Turnover	0.90x	0.90x	0.72x	0.85x	0.72x	0.68x	0.58x	0.69x	0.72x	0.68x
Asset Growth %	0.05%	0.02%	0.71%	-0.01%	0.21%	-0.01%	0.42%	0.01%	-0.01%	0.13%
Total Current Liabilities+	56.95M	70.5M	98.17M	104.2M	134.85M	114.23M	183.94M	164.52M	139.18M	167.79M
Accounts Payable	24.4M	32.21M	39.79M	50.73M	52.59M	42.97M	68.51M	75.22M	57.2M	76.89M
Days Payables Outstanding	41.29	52.89	48.29	52.49	52.73	45.31	61.52	56.91	43.33	53.18
Short-Term Debt	7.38M	7.37M	9.12M	4.54M	10.07M	21.42M	13.03M	13.26M	13.88M	15.33M
Deferred Revenue (Current)	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	13.82M	17.3M	25.97M	17.59M	51.75M	25.38M	66.16M	18.75M	22.08M	25.5M
Current Ratio	3.25x	2.83x	2.93x	2.70x	2.26x	2.66x	2.03x	2.56x	2.98x	2.58x
Quick Ratio	2.21x	1.98x	2.00x	1.70x	1.39x	1.85x	1.35x	1.53x	1.91x	1.72x
Cash Conversion Cycle	117.83	105.7	119.53	105.78	117.3	98.87	111.02	128.57	127.55	104.91
Total Non-Current Liabilities+	114.39M	96.27M	270.07M	247.13M	317.72M	274.14M	522.65M	499.1M	413.42M	475.02M
Long-Term Debt	88.43M	70.55M	225.5M	202.84M	215.33M	194.93M	429.36M	430.66M	349.4M	411.95M
Capital Lease Obligations	9.17M	8.11M	0	7.28M	48.95M	38.71M	51.01M	45.46M	41.28M	43.72M
Deferred Tax Liabilities	449K	1.29M	25.67M	22.63M	26.68M	24.13M	33.74M	17.19M	16.3M	13.09M
Other Non-Current Liabilities	16.34M	16.31M	18.89M	14.38M	26.75M	16.37M	8.55M	5.79M	6.43M	6.26M
Total Liabilities	171.34M	166.77M	368.24M	351.32M	452.56M	388.37M	706.59M	663.63M	552.6M	642.81M
Total Debt+	104.98M	86.03M	234.62M	207.38M	275.67M	255.05M	493.4M	489.38M	404.56M	471M
Net Debt	45.02M	17.92M	134.56M	125.33M	196.72M	130M	376.01M	389.28M	299.51M	357.01M
Debt / Equity	0.43x	0.33x	0.65x	0.56x	0.66x	0.53x	0.95x	0.85x	0.60x	0.63x
Debt / EBITDA	2.19x	1.61x	2.66x	1.92x	2.95x	2.71x	4.59x	3.13x	2.58x	2.83x
Net Debt / EBITDA	0.94x	0.34x	1.52x	1.16x	2.10x	1.38x	3.50x	2.49x	1.91x	2.15x
Interest Coverage	5.59x	7.23x	8.03x	7.24x	6.51x	8.51x	-	-	-	-
Total Equity+	244.7M	258.87M	358.47M	368.25M	417.17M	476.81M	521.29M	577.59M	673.46M	745.7M
Equity Growth %	0.16%	0.06%	0.38%	0.03%	0.13%	0.14%	0.09%	0.11%	0.17%	0.11%
Book Value per Share	7.03	7.41	10.16	10.38	11.74	13.37	14.57	16.08	18.69	20.64
Total Shareholders' Equity	244.7M	258.87M	311.55M	368.25M	417.17M	476.81M	521.29M	577.59M	673.46M	745.7M
Common Stock	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M
Retained Earnings	-189.55M	-167.55M	-127.74M	-79.09M	-38.32M	6.2M	56.53M	130.58M	203.46M	267.55M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-18.83M	-27.71M	-17.88M	-22.53M	-18.11M	-12.24M	-12.87M	-32.01M	-24.04M	-29.92M
Minority Interest	0	0	46.92M	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	33.42M	47.79M	63.38M	89.65M	63.25M	140.24M	94.63M	90.78M	120.08M	158.51M
Operating CF Margin %	0.09%	0.12%	0.12%	0.15%	0.1%	0.24%	0.13%	0.11%	0.14%	0.17%
Operating CF Growth %	-0.21%	0.43%	0.33%	0.41%	-0.29%	1.22%	-0.33%	-0.04%	0.32%	0.32%
Net Income	35.63M	22M	62.31M	50.89M	40.77M	44.52M	50.33M	74.05M	72.88M	64.09M
Depreciation & Amortization	19.11M	20.36M	30.76M	37.05M	38.28M	38.29M	43.39M	53.16M	46.61M	55.56M
Stock-Based Compensation	4.39M	4.29M	5.49M	7.71M	9.34M	23.12M	25.61M	23.11M	25.59M	23.31M
Deferred Taxes	-1.69M	-1.77M	-2.56M	-6.08M	-4.33M	-4.11M	-3.94M	-18.65M	-14.73M	-15.91M
Other Non-Cash Items	-17.59M	4.67M	-18.77M	3M	6.63M	-1.12M	6.25M	3.85M	11.05M	12.55M
Working Capital Changes	-6.43M	-1.77M	-13.85M	-2.93M	-27.44M	39.54M	-27.01M	-44.74M	-21.33M	18.92M
Change in Receivables	-7.53M	-6.39M	-2.08M	-1.16M	-3.6M	18.03M	-25.36M	-23.25M	-127K	-6.19M
Change in Inventory	-3.34M	-2.92M	-13.59M	-15.6M	-7.4M	22.1M	-19.08M	-48.55M	11.37M	4.78M
Change in Payables	2.17M	10.59M	8.99M	11.24M	-14.8M	-14.48M	24.52M	30.33M	-20.45M	13.06M
Cash from Investing+	-1.63M	-12.87M	-177.38M	-45.59M	-63.84M	-13.16M	-306.7M	-42.54M	-19.89M	-208.19M
Capital Expenditures	-5.55M	-8.46M	-9.09M	-14.66M	-10.74M	-10.52M	-22.18M	-19.64M	-19.96M	-17.16M
CapEx % of Revenue	0.01%	0.02%	0.02%	0.02%	0.02%	0.02%	0.03%	0.02%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	336K	4.55M	46K	-1.33M	42K	-2.63M	200K	-1.33M	69K	173K
Cash from Financing+	-21.54M	-23.19M	143.33M	-60.16M	-3.94M	-84.36M	204.75M	-60.15M	-97.85M	56.94M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-467K	-5.3M	-4.05M	-31.36M	-3.1M	-43.47M	-34.12M	-49.34M	-11.3M	-9.99M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	27.86M	39.33M	54.28M	74.99M	52.51M	129.72M	72.45M	71.14M	100.11M	141.35M
FCF Margin %	0.07%	0.1%	0.1%	0.12%	0.08%	0.22%	0.1%	0.08%	0.11%	0.15%
FCF Growth %	-0.24%	0.41%	0.38%	0.38%	-0.3%	1.47%	-0.44%	-0.02%	0.41%	0.41%
FCF per Share	0.80	1.13	1.54	2.11	1.48	3.64	2.02	1.98	2.78	3.91
FCF Conversion (FCF/Net Income)	0.94x	2.17x	1.06x	1.83x	1.55x	3.15x	1.88x	1.23x	1.65x	2.47x
Interest Paid	3.78M	2.92M	5.83M	8.92M	8.39M	5.53M	6.21M	14.26M	25.3M	32.67M
Taxes Paid	10.69M	14.06M	21.12M	20.32M	14.26M	5.88M	11.3M	20.29M	36.9M	21.15M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	15.62%	8.74%	19.45%	13.52%	10.38%	9.96%	10.09%	13.48%	11.65%	9.03%
Return on Invested Capital (ROIC)	7.59%	8.73%	11.22%	10.8%	7.49%	6.87%	6.39%	8.29%	8.54%	7.99%
Gross Margin	42.26%	42.22%	42.3%	42.57%	41.86%	41.4%	42.49%	43.96%	45.36%	44.41%
Net Margin	9.53%	5.72%	11.52%	7.99%	6.51%	7.54%	7.12%	8.6%	8.27%	6.75%
Debt / Equity	0.43x	0.33x	0.65x	0.56x	0.66x	0.53x	0.95x	0.85x	0.60x	0.63x
Interest Coverage	5.59x	7.23x	8.03x	7.24x	6.51x	8.51x	-	-	-	-
FCF Conversion	0.94x	2.17x	1.06x	1.83x	1.55x	3.15x	1.88x	1.23x	1.65x	2.47x
Revenue Growth	2.44%	2.99%	35.49%	17.85%	1.91%	-5.67%	19.67%	21.8%	2.41%	7.67%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Robotics and Automation	-	-	-	-	-	-	-	-	273.47M	288.32M
Robotics and Automation Growth	-	-	-	-	-	-	-	-	-	5.43%
Precision Medicine	-	-	-	-	-	-	-	-	-	249.87M
Precision Medicine Growth	-	-	-	-	-	-	-	-	-	-
Advanced Surgery	-	-	-	-	-	-	-	-	-	208.75M
Advanced Surgery Growth	-	-	-	-	-	-	-	-	-	-
Precision Manufacturing	-	-	-	-	-	-	-	-	-	202.3M
Precision Manufacturing Growth	-	-	-	-	-	-	-	-	-	-
Medical Solutions	-	-	-	-	-	-	-	-	325.22M	-
Medical Solutions Growth	-	-	-	-	-	-	-	-	-	-
Precision Medicine and Manufacturing	-	-	-	-	-	-	-	-	282.97M	-
Precision Medicine and Manufacturing Growth	-	-	-	-	-	-	-	-	-	-
Precision Motion	80.54M	88.35M	105.86M	132.1M	124.23M	129.36M	212.27M	308.24M	-	-
Precision Motion Growth	-	9.69%	19.82%	24.79%	-5.95%	4.13%	64.10%	45.21%	-	-
Vision	-	122.25M	183.07M	232.9M	271.41M	261.65M	262.06M	277.99M	-	-
Vision Growth	-	-	49.75%	27.22%	16.53%	-3.59%	0.16%	6.08%	-	-
Photonics	-	174.16M	232.36M	249.34M	230.46M	199.61M	232.46M	274.67M	-	-
Photonics Growth	-	-	33.42%	7.31%	-7.57%	-13.38%	16.45%	18.16%	-	-
Laser Products	168.33M	-	-	-	-	-	-	-	-	-
Laser Products Growth	-	-	-	-	-	-	-	-	-	-
Vision Technologies	124.72M	-	-	-	-	-	-	-	-	-
Vision Technologies Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	-	154.76M	220.58M	242.24M	254.28M	225.76M	270.83M	372.35M	418.26M	487.11M
UNITED STATES Growth	-	-	42.54%	9.82%	4.97%	-11.22%	19.97%	37.48%	12.33%	16.46%
Rest Of Europe	-	51.7M	81M	105.61M	129.64M	127.04M	138.86M	137.8M	137.03M	128.87M
Rest Of Europe Growth	-	-	56.66%	30.38%	22.76%	-2.01%	9.31%	-0.76%	-0.56%	-5.95%
GERMANY	-	55.94M	68M	88.03M	82.03M	83.77M	101.86M	133.73M	128.23M	123.24M
GERMANY Growth	-	-	21.56%	29.45%	-6.81%	2.11%	21.61%	31.28%	-4.11%	-3.89%
Rest Of Asia Pacific	-	60.1M	84.73M	104.3M	89.59M	74.33M	89.2M	101.6M	105.35M	107.05M
Rest Of Asia Pacific Growth	-	-	40.97%	23.10%	-14.11%	-17.03%	20.00%	13.90%	3.70%	1.62%
CHINA	-	44.23M	56.13M	66.41M	59.51M	70.56M	95.05M	97.18M	73.44M	84.56M
CHINA Growth	-	-	26.91%	18.33%	-10.39%	18.56%	34.71%	2.24%	-24.42%	15.14%
Other Countries	14.79M	18.03M	10.85M	7.75M	11.04M	9.17M	10.99M	18.25M	19.35M	18.4M
Other Countries Growth	-	21.85%	-39.83%	-28.60%	42.61%	-17.00%	19.88%	66.10%	5.99%	-4.89%
U S	154.82M	-	-	-	-	-	-	-	-	-
U S Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Novanta Inc. (NOVT) has a price-to-earnings (P/E) ratio of 75.2x. This suggests investors expect higher future growth.

Growth & Financials

Novanta Inc. (NOVT) reported $960.3M in revenue for fiscal year 2024. This represents a 162% increase from $366.3M in 2011.

Novanta Inc. (NOVT) grew revenue by 7.7% over the past year. This is steady growth.

Yes, Novanta Inc. (NOVT) is profitable, generating $52.8M in net income for fiscal year 2024 (6.8% net margin).

Dividend & Returns

Novanta Inc. (NOVT) has a return on equity (ROE) of 9.0%. This is below average, suggesting room for improvement.

Novanta Inc. (NOVT) generated $102.6M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Novanta Inc. (NOVT) 10-Year Financial Performance & Capital Metrics

NOVT • • Industrial / General

TechnologyTech Hardware & EquipmentOptical & Photonics SystemsLaser & Optical Components

Revenue $949M +7.7%
EBITDA $166M +5.8%
Net Income $64M -12.1%
EPS (Diluted) 1.77 -12.4%
Gross Margin 44.41% -2.1%
EBITDA Margin 17.5% -1.8%
Operating Margin 11.65% -7.0%
Net Margin 6.75% -18.3%
ROE 9.03% -22.5%
ROIC 7.99% -6.5%
Debt/Equity 0.63 +5.1%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗Weak Piotroski F-Score: 3/9

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y10.04%

5Y8.68%

3Y10.33%

TTM4.07%

Profit (Net Income) CAGR

10Y-

5Y9.47%

3Y8.39%

TTM-12.16%

EPS CAGR

10Y-

5Y9.01%

3Y7.87%

TTM-11.98%

ROCE

10Y Avg9.3%

5Y Avg8.84%

3Y Avg9.84%

Latest9.58%

Peer Comparison

Laser & Optical Components

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
NOVTNovanta Inc.	4.76B	133.18	75.24	7.67%	5.5%	6.59%	2.97%	0.63
SELXSemilux International Ltd. Ordinary Shares	34.43M	0.92	-0.15	-67.94%	-165.22%	-31.41%		0.52
COHRCoherent, Inc.	30.8B	195.96	-376.85	23.42%	4.13%	2.88%	0.63%	0.46

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	373.6M	384.76M	521.29M	614.34M	626.1M	590.62M	706.79M	860.9M	881.66M	949.25M
Revenue Growth %	0.02%	0.03%	0.35%	0.18%	0.02%	-0.06%	0.2%	0.22%	0.02%	0.08%
Cost of Goods Sold+	215.71M	222.31M	300.76M	352.81M	364.01M	346.11M	406.46M	482.43M	481.76M	527.7M
COGS % of Revenue	0.58%	0.58%	0.58%	0.57%	0.58%	0.59%	0.58%	0.56%	0.55%	0.56%
Gross Profit+	157.89M	162.45M	220.53M	261.53M	262.08M	244.52M	300.33M	378.47M	399.9M	421.55M
Gross Margin %	0.42%	0.42%	0.42%	0.43%	0.42%	0.41%	0.42%	0.44%	0.45%	0.44%
Gross Profit Growth %	0.05%	0.03%	0.36%	0.19%	0%	-0.07%	0.23%	0.26%	0.06%	0.05%
Operating Expenses+	128.96M	129.5M	162.97M	190.51M	206.8M	188.63M	236.27M	275.39M	289.4M	310.96M
OpEx % of Revenue	0.35%	0.34%	0.31%	0.31%	0.33%	0.32%	0.33%	0.32%	0.33%	0.33%
Selling, General & Admin	82.05M	81.69M	102.03M	115.9M	118.41M	109.85M	129.16M	158.9M	164.46M	175.94M
SG&A % of Revenue	0.22%	0.21%	0.2%	0.19%	0.19%	0.19%	0.18%	0.18%	0.19%	0.19%
Research & Development	31.04M	32M	41.67M	51.02M	55.97M	61M	72.52M	85.77M	91.68M	95.52M
R&D % of Revenue	0.08%	0.08%	0.08%	0.08%	0.09%	0.1%	0.1%	0.1%	0.1%	0.1%
Other Operating Expenses	15.87M	15.8M	19.27M	23.59M	32.43M	17.78M	34.6M	30.72M	33.26M	39.5M
Operating Income+	28.93M	32.95M	57.57M	71.01M	55.28M	55.89M	64.05M	103.08M	110.5M	110.58M
Operating Margin %	0.08%	0.09%	0.11%	0.12%	0.09%	0.09%	0.09%	0.12%	0.13%	0.12%
Operating Income Growth %	2.72%	0.14%	0.75%	0.23%	-0.22%	0.01%	0.15%	0.61%	0.07%	0%
EBITDA+	48.05M	53.31M	88.32M	108.06M	93.56M	94.18M	107.45M	156.24M	157.11M	166.15M
EBITDA Margin %	0.13%	0.14%	0.17%	0.18%	0.15%	0.16%	0.15%	0.18%	0.18%	0.18%
EBITDA Growth %	5.87%	0.11%	0.66%	0.22%	-0.13%	0.01%	0.14%	0.45%	0.01%	0.06%
D&A (Non-Cash Add-back)	19.11M	20.36M	30.76M	37.05M	38.28M	38.29M	43.39M	53.16M	46.61M	55.56M
EBIT	37.19M	40.9M	65.11M	79.05M	71.86M	59.7M	82.07M	107.46M	123.31M	124.29M
Net Interest Income+	-5.18M	-4.56M	-7.17M	-9.81M	-8.49M	-6.56M	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	5.18M	4.56M	7.17M	9.81M	8.49M	6.56M	0	0	0	0
Other Income/Expense	17.09M	-433K	18.57M	-9.71M	-9.52M	-7.49M	-7.88M	-15.92M	-26.75M	-31.52M
Pretax Income+	46.02M	32.52M	76.13M	61.3M	45.77M	48.4M	56.17M	87.16M	83.75M	79.07M
Pretax Margin %	0.12%	0.08%	0.15%	0.1%	0.07%	0.08%	0.08%	0.1%	0.09%	0.08%
Income Tax+	10.39M	10.52M	13.83M	10.21M	4.99M	3.88M	5.84M	13.11M	10.87M	14.98M
Effective Tax Rate %	0.77%	0.68%	0.79%	0.8%	0.89%	0.92%	0.9%	0.85%	0.87%	0.81%
Net Income+	35.62M	22M	60.05M	49.11M	40.77M	44.52M	50.33M	74.05M	72.88M	64.09M
Net Margin %	0.1%	0.06%	0.12%	0.08%	0.07%	0.08%	0.07%	0.09%	0.08%	0.07%
Net Income Growth %	2.47%	-0.38%	1.73%	-0.18%	-0.17%	0.09%	0.13%	0.47%	-0.02%	-0.12%
Net Income (Continuing)	35.63M	22M	62.31M	51.09M	40.77M	44.52M	50.33M	74.05M	72.88M	64.09M
Discontinued Operations	-13K	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	46.92M	0	0	0	0	0	0	0
EPS (Diluted)+	1.02	0.63	1.13	1.43	1.15	1.25	1.41	2.06	2.02	1.77
EPS Growth %	2.46%	-0.38%	0.79%	0.27%	-0.2%	0.09%	0.13%	0.46%	-0.02%	-0.12%
EPS (Basic)	1.03	0.63	1.14	1.46	1.16	1.27	1.42	2.08	2.03	1.78
Diluted Shares Outstanding	34.83M	34.91M	35.28M	35.47M	35.55M	35.65M	35.78M	35.91M	36.03M	36.12M
Basic Shares Outstanding	34.58M	34.69M	34.82M	34.91M	35.03M	35.14M	35.4M	35.65M	35.84M	35.95M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	185.21M	199.25M	287.88M	281.77M	304.51M	304.17M	373.82M	420.52M	415.3M	433.65M
Cash & Short-Term Investments	59.96M	68.11M	100.06M	82.04M	78.94M	125.05M	117.39M	100.11M	105.05M	113.99M
Cash Only	59.96M	68.11M	100.06M	82.04M	78.94M	125.05M	117.39M	100.11M	105.05M	113.99M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	59.7M	63.77M	81.48M	83.95M	91.08M	75.05M	115.62M	137.7M	139.41M	151.03M
Days Sales Outstanding	58.32	60.49	57.05	49.88	53.1	46.38	59.71	58.38	57.71	58.07
Inventory	59.57M	59.74M	91.28M	104.76M	116.62M	92.74M	125.66M	168M	149.37M	144.61M
Days Inventory Outstanding	100.79	98.09	110.77	108.38	116.93	97.8	112.84	127.1	113.17	100.02
Other Current Assets	5.99M	7.63M	15.06M	11.01M	17.87M	11.33M	15.16M	14.72M	21.46M	24.03M
Total Non-Current Assets+	230.83M	226.39M	438.82M	437.81M	565.22M	561.01M	854.06M	820.69M	810.76M	954.86M
Property, Plant & Equipment	40.55M	35.42M	61.72M	65.46M	112.74M	113.12M	135.78M	146.5M	147.75M	156.04M
Fixed Asset Turnover	9.21x	10.86x	8.45x	9.38x	5.55x	5.22x	5.21x	5.88x	5.97x	6.08x
Goodwill	103.46M	108.13M	210.99M	217.66M	274.71M	285.98M	479.5M	478.9M	484.51M	584.1M
Intangible Assets	66.27M	61.74M	155.05M	142.92M	166.18M	148.52M	220.99M	175.77M	145.02M	185.84M
Long-Term Investments	10.1M	8.5M	0	0	0	0	0	0	0	0
Other Non-Current Assets	12.67M	12.5M	4.02M	2.27M	2.71M	2.89M	5.59M	4.41M	5.62M	5.99M
Total Assets+	416.05M	425.64M	726.7M	719.58M	869.74M	865.18M	1.23B	1.24B	1.23B	1.39B
Asset Turnover	0.90x	0.90x	0.72x	0.85x	0.72x	0.68x	0.58x	0.69x	0.72x	0.68x
Asset Growth %	0.05%	0.02%	0.71%	-0.01%	0.21%	-0.01%	0.42%	0.01%	-0.01%	0.13%
Total Current Liabilities+	56.95M	70.5M	98.17M	104.2M	134.85M	114.23M	183.94M	164.52M	139.18M	167.79M
Accounts Payable	24.4M	32.21M	39.79M	50.73M	52.59M	42.97M	68.51M	75.22M	57.2M	76.89M
Days Payables Outstanding	41.29	52.89	48.29	52.49	52.73	45.31	61.52	56.91	43.33	53.18
Short-Term Debt	7.38M	7.37M	9.12M	4.54M	10.07M	21.42M	13.03M	13.26M	13.88M	15.33M
Deferred Revenue (Current)	0	0	0	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	13.82M	17.3M	25.97M	17.59M	51.75M	25.38M	66.16M	18.75M	22.08M	25.5M
Current Ratio	3.25x	2.83x	2.93x	2.70x	2.26x	2.66x	2.03x	2.56x	2.98x	2.58x
Quick Ratio	2.21x	1.98x	2.00x	1.70x	1.39x	1.85x	1.35x	1.53x	1.91x	1.72x
Cash Conversion Cycle	117.83	105.7	119.53	105.78	117.3	98.87	111.02	128.57	127.55	104.91
Total Non-Current Liabilities+	114.39M	96.27M	270.07M	247.13M	317.72M	274.14M	522.65M	499.1M	413.42M	475.02M
Long-Term Debt	88.43M	70.55M	225.5M	202.84M	215.33M	194.93M	429.36M	430.66M	349.4M	411.95M
Capital Lease Obligations	9.17M	8.11M	0	7.28M	48.95M	38.71M	51.01M	45.46M	41.28M	43.72M
Deferred Tax Liabilities	449K	1.29M	25.67M	22.63M	26.68M	24.13M	33.74M	17.19M	16.3M	13.09M
Other Non-Current Liabilities	16.34M	16.31M	18.89M	14.38M	26.75M	16.37M	8.55M	5.79M	6.43M	6.26M
Total Liabilities	171.34M	166.77M	368.24M	351.32M	452.56M	388.37M	706.59M	663.63M	552.6M	642.81M
Total Debt+	104.98M	86.03M	234.62M	207.38M	275.67M	255.05M	493.4M	489.38M	404.56M	471M
Net Debt	45.02M	17.92M	134.56M	125.33M	196.72M	130M	376.01M	389.28M	299.51M	357.01M
Debt / Equity	0.43x	0.33x	0.65x	0.56x	0.66x	0.53x	0.95x	0.85x	0.60x	0.63x
Debt / EBITDA	2.19x	1.61x	2.66x	1.92x	2.95x	2.71x	4.59x	3.13x	2.58x	2.83x
Net Debt / EBITDA	0.94x	0.34x	1.52x	1.16x	2.10x	1.38x	3.50x	2.49x	1.91x	2.15x
Interest Coverage	5.59x	7.23x	8.03x	7.24x	6.51x	8.51x	-	-	-	-
Total Equity+	244.7M	258.87M	358.47M	368.25M	417.17M	476.81M	521.29M	577.59M	673.46M	745.7M
Equity Growth %	0.16%	0.06%	0.38%	0.03%	0.13%	0.14%	0.09%	0.11%	0.17%	0.11%
Book Value per Share	7.03	7.41	10.16	10.38	11.74	13.37	14.57	16.08	18.69	20.64
Total Shareholders' Equity	244.7M	258.87M	311.55M	368.25M	417.17M	476.81M	521.29M	577.59M	673.46M	745.7M
Common Stock	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M	423.86M
Retained Earnings	-189.55M	-167.55M	-127.74M	-79.09M	-38.32M	6.2M	56.53M	130.58M	203.46M	267.55M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-18.83M	-27.71M	-17.88M	-22.53M	-18.11M	-12.24M	-12.87M	-32.01M	-24.04M	-29.92M
Minority Interest	0	0	46.92M	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	33.42M	47.79M	63.38M	89.65M	63.25M	140.24M	94.63M	90.78M	120.08M	158.51M
Operating CF Margin %	0.09%	0.12%	0.12%	0.15%	0.1%	0.24%	0.13%	0.11%	0.14%	0.17%
Operating CF Growth %	-0.21%	0.43%	0.33%	0.41%	-0.29%	1.22%	-0.33%	-0.04%	0.32%	0.32%
Net Income	35.63M	22M	62.31M	50.89M	40.77M	44.52M	50.33M	74.05M	72.88M	64.09M
Depreciation & Amortization	19.11M	20.36M	30.76M	37.05M	38.28M	38.29M	43.39M	53.16M	46.61M	55.56M
Stock-Based Compensation	4.39M	4.29M	5.49M	7.71M	9.34M	23.12M	25.61M	23.11M	25.59M	23.31M
Deferred Taxes	-1.69M	-1.77M	-2.56M	-6.08M	-4.33M	-4.11M	-3.94M	-18.65M	-14.73M	-15.91M
Other Non-Cash Items	-17.59M	4.67M	-18.77M	3M	6.63M	-1.12M	6.25M	3.85M	11.05M	12.55M
Working Capital Changes	-6.43M	-1.77M	-13.85M	-2.93M	-27.44M	39.54M	-27.01M	-44.74M	-21.33M	18.92M
Change in Receivables	-7.53M	-6.39M	-2.08M	-1.16M	-3.6M	18.03M	-25.36M	-23.25M	-127K	-6.19M
Change in Inventory	-3.34M	-2.92M	-13.59M	-15.6M	-7.4M	22.1M	-19.08M	-48.55M	11.37M	4.78M
Change in Payables	2.17M	10.59M	8.99M	11.24M	-14.8M	-14.48M	24.52M	30.33M	-20.45M	13.06M
Cash from Investing+	-1.63M	-12.87M	-177.38M	-45.59M	-63.84M	-13.16M	-306.7M	-42.54M	-19.89M	-208.19M
Capital Expenditures	-5.55M	-8.46M	-9.09M	-14.66M	-10.74M	-10.52M	-22.18M	-19.64M	-19.96M	-17.16M
CapEx % of Revenue	0.01%	0.02%	0.02%	0.02%	0.02%	0.02%	0.03%	0.02%	0.02%	0.02%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	336K	4.55M	46K	-1.33M	42K	-2.63M	200K	-1.33M	69K	173K
Cash from Financing+	-21.54M	-23.19M	143.33M	-60.16M	-3.94M	-84.36M	204.75M	-60.15M	-97.85M	56.94M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-467K	-5.3M	-4.05M	-31.36M	-3.1M	-43.47M	-34.12M	-49.34M	-11.3M	-9.99M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	27.86M	39.33M	54.28M	74.99M	52.51M	129.72M	72.45M	71.14M	100.11M	141.35M
FCF Margin %	0.07%	0.1%	0.1%	0.12%	0.08%	0.22%	0.1%	0.08%	0.11%	0.15%
FCF Growth %	-0.24%	0.41%	0.38%	0.38%	-0.3%	1.47%	-0.44%	-0.02%	0.41%	0.41%
FCF per Share	0.80	1.13	1.54	2.11	1.48	3.64	2.02	1.98	2.78	3.91
FCF Conversion (FCF/Net Income)	0.94x	2.17x	1.06x	1.83x	1.55x	3.15x	1.88x	1.23x	1.65x	2.47x
Interest Paid	3.78M	2.92M	5.83M	8.92M	8.39M	5.53M	6.21M	14.26M	25.3M	32.67M
Taxes Paid	10.69M	14.06M	21.12M	20.32M	14.26M	5.88M	11.3M	20.29M	36.9M	21.15M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	15.62%	8.74%	19.45%	13.52%	10.38%	9.96%	10.09%	13.48%	11.65%	9.03%
Return on Invested Capital (ROIC)	7.59%	8.73%	11.22%	10.8%	7.49%	6.87%	6.39%	8.29%	8.54%	7.99%
Gross Margin	42.26%	42.22%	42.3%	42.57%	41.86%	41.4%	42.49%	43.96%	45.36%	44.41%
Net Margin	9.53%	5.72%	11.52%	7.99%	6.51%	7.54%	7.12%	8.6%	8.27%	6.75%
Debt / Equity	0.43x	0.33x	0.65x	0.56x	0.66x	0.53x	0.95x	0.85x	0.60x	0.63x
Interest Coverage	5.59x	7.23x	8.03x	7.24x	6.51x	8.51x	-	-	-	-
FCF Conversion	0.94x	2.17x	1.06x	1.83x	1.55x	3.15x	1.88x	1.23x	1.65x	2.47x
Revenue Growth	2.44%	2.99%	35.49%	17.85%	1.91%	-5.67%	19.67%	21.8%	2.41%	7.67%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Robotics and Automation	-	-	-	-	-	-	-	-	273.47M	288.32M
Robotics and Automation Growth	-	-	-	-	-	-	-	-	-	5.43%
Precision Medicine	-	-	-	-	-	-	-	-	-	249.87M
Precision Medicine Growth	-	-	-	-	-	-	-	-	-	-
Advanced Surgery	-	-	-	-	-	-	-	-	-	208.75M
Advanced Surgery Growth	-	-	-	-	-	-	-	-	-	-
Precision Manufacturing	-	-	-	-	-	-	-	-	-	202.3M
Precision Manufacturing Growth	-	-	-	-	-	-	-	-	-	-
Medical Solutions	-	-	-	-	-	-	-	-	325.22M	-
Medical Solutions Growth	-	-	-	-	-	-	-	-	-	-
Precision Medicine and Manufacturing	-	-	-	-	-	-	-	-	282.97M	-
Precision Medicine and Manufacturing Growth	-	-	-	-	-	-	-	-	-	-
Precision Motion	80.54M	88.35M	105.86M	132.1M	124.23M	129.36M	212.27M	308.24M	-	-
Precision Motion Growth	-	9.69%	19.82%	24.79%	-5.95%	4.13%	64.10%	45.21%	-	-
Vision	-	122.25M	183.07M	232.9M	271.41M	261.65M	262.06M	277.99M	-	-
Vision Growth	-	-	49.75%	27.22%	16.53%	-3.59%	0.16%	6.08%	-	-
Photonics	-	174.16M	232.36M	249.34M	230.46M	199.61M	232.46M	274.67M	-	-
Photonics Growth	-	-	33.42%	7.31%	-7.57%	-13.38%	16.45%	18.16%	-	-
Laser Products	168.33M	-	-	-	-	-	-	-	-	-
Laser Products Growth	-	-	-	-	-	-	-	-	-	-
Vision Technologies	124.72M	-	-	-	-	-	-	-	-	-
Vision Technologies Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	-	154.76M	220.58M	242.24M	254.28M	225.76M	270.83M	372.35M	418.26M	487.11M
UNITED STATES Growth	-	-	42.54%	9.82%	4.97%	-11.22%	19.97%	37.48%	12.33%	16.46%
Rest Of Europe	-	51.7M	81M	105.61M	129.64M	127.04M	138.86M	137.8M	137.03M	128.87M
Rest Of Europe Growth	-	-	56.66%	30.38%	22.76%	-2.01%	9.31%	-0.76%	-0.56%	-5.95%
GERMANY	-	55.94M	68M	88.03M	82.03M	83.77M	101.86M	133.73M	128.23M	123.24M
GERMANY Growth	-	-	21.56%	29.45%	-6.81%	2.11%	21.61%	31.28%	-4.11%	-3.89%
Rest Of Asia Pacific	-	60.1M	84.73M	104.3M	89.59M	74.33M	89.2M	101.6M	105.35M	107.05M
Rest Of Asia Pacific Growth	-	-	40.97%	23.10%	-14.11%	-17.03%	20.00%	13.90%	3.70%	1.62%
CHINA	-	44.23M	56.13M	66.41M	59.51M	70.56M	95.05M	97.18M	73.44M	84.56M
CHINA Growth	-	-	26.91%	18.33%	-10.39%	18.56%	34.71%	2.24%	-24.42%	15.14%
Other Countries	14.79M	18.03M	10.85M	7.75M	11.04M	9.17M	10.99M	18.25M	19.35M	18.4M
Other Countries Growth	-	21.85%	-39.83%	-28.60%	42.61%	-17.00%	19.88%	66.10%	5.99%	-4.89%
U S	154.82M	-	-	-	-	-	-	-	-	-
U S Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

Novanta Inc. (NOVT) has a price-to-earnings (P/E) ratio of 75.2x. This suggests investors expect higher future growth.

Growth & Financials

Novanta Inc. (NOVT) reported $960.3M in revenue for fiscal year 2024. This represents a 162% increase from $366.3M in 2011.

Novanta Inc. (NOVT) grew revenue by 7.7% over the past year. This is steady growth.

Yes, Novanta Inc. (NOVT) is profitable, generating $52.8M in net income for fiscal year 2024 (6.8% net margin).

Dividend & Returns

Novanta Inc. (NOVT) has a return on equity (ROE) of 9.0%. This is below average, suggesting room for improvement.

Novanta Inc. (NOVT) generated $102.6M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.